Near-infrared fluorescent probe for detecting epinephrine and noradrenaline as well as preparation method and application of near-infrared fluorescent probe
Through fluorescent probes with silicon rhodamine and thiocarbonate structures, efficient detection of adrenaline and norepinephrine is achieved, solving the detection problems in the prior art, and providing a fast, simple and low-cost solution , has a wide range of biomedical application prospects.
Patent Information
- Application Number
- CN202411025468.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-29
- Publication Date
- 2024-11-15
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
The prior art is difficult to detect adrenaline and norepinephrine quickly, easily and at low cost, resulting in difficulties in the diagnosis and treatment of central nervous system diseases.
A fluorescent probe based on the structure of silicon rhodamine and thiocarbonate was developed to achieve intramolecular nucleophilic cyclization with adrenaline and norepinephrine through a specific reaction, releasing fluorophores, thereby achieving the Efficient detection.
This fluorescent probe can achieve more than 10 times enhancement of background fluorescence within 60 minutes, with an emission wavelength of 668nm, with good pH universality and high efficiency, and is suitable for detection in the field of biomedical science.
Smart Images

Figure CN118955551A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to a fluorescent probe, a preparation method and an application thereof, and more particularly to a fluorescent probe for detecting adrenaline and noradrenaline, a preparation method and an application thereof. Background Art
[0002] In recent years, depression has become a global disease burden with high morbidity, mortality and disability rates. Neurotransmitters are considered to be the "dark matter" in the brain. Pathological analysis methods are separated from their natural biological background, resulting in unclear etiology and pathogenesis of central nervous system (CNS) diseases. Current research and diagnostic methods make it difficult to improve the clinical cure rate of patients.
[0003] Catecholamine neurotransmitters are very similar in structure and chemical properties, including epinephrine (EP), norepinephrine (NE), and dopamine (DA). The depletion levels of these neurotransmitters in human body fluids are associated with Alzheimer's disease, Parkinson's disease, schizophrenia, attention deficit, Huntington's disease, and depression. Therefore, monitoring the concentration of these catecholamines as biomarkers is a promising strategy for early detection and treatment of these devastating diseases.
[0004] EP is an important neurotransmitter in the central nervous system. It is secreted by the adrenal medulla and is a catecholamine compound. It is reported that the concentration of EP in the blood and urine is related to the occurrence of neurological disorders such as Alzheimer's disease and Parkinson's disease. In addition, medical reports show that the release of EP is closely related to many intense activities, such as fighting, flying, and even accelerating the heartbeat when excited or afraid.
[0005] NE, as one of the most important neurotransmitters in the sympathetic nervous system, plays a key role in all forebrain activities such as perception, memory, learning and homeostasis. Its metabolic abnormalities are closely related to neurodegenerative diseases and central nervous system diseases. Effective monitoring of NE fluctuations is helpful for the diagnosis of depression and the evaluation of the efficacy of antidepressant drug interventions. There is still an urgent need to construct a new fluorescent probe with high specificity for NE for imaging in depression models.
[0006] Therefore, researching and developing a rapid, simple and low-cost method to detect EP and NE is crucial for health diagnosis. In this work, a fluorescent probe was developed that can specifically recognize epinephrine and norepinephrine. Summary of the invention
[0007] The technical problem to be solved by the present invention is to make up for the deficiencies of the prior art and provide a fluorescent probe for detecting adrenaline and noradrenaline. The fluorescent probe is constructed with silicon rhodamine as a parent and a thiocarbonate structure as a recognition group. Under the condition that adrenaline and noradrenaline exist, the probe reacts specifically with them. The primary amine and secondary amine of NE and EP attack the carbonate of the probe with their strong nucleophilicity, and further undergo intramolecular nucleophilic cyclization with its β-OH, thereby inducing 1,6 elimination and releasing the fluorescent group silicon rhodamine, thereby realizing the specific detection of adrenaline and noradrenaline, and will have a good application prospect in the field of biological sciences.
[0008] The invention also provides a preparation method and application of the fluorescent probe.
[0009] The technical solution of the present invention to solve the technical problem is as follows:
[0010] The fluorescent probe for detecting adrenaline and norepinephrine of the present invention has a structure as shown in Formula VI:
[0011]
[0012] The present invention also provides a method for preparing the above-mentioned probe molecule, the specific process is:
[0013] (1) Under nitrogen protection, add 3-bromo-N,N-dimethylaniline and solvent to a dry flask equipped with a magnetic rod. Cool the solution to -78°C, add a strong base to the reaction flask, and continue stirring at -78°C for 2 hours. Add dichlorodimethylsilane dropwise to the reaction flask, slowly warm the reaction mixture to room temperature after the addition is complete, and then continue stirring for 12 hours. Separate and purify to obtain compound I;
[0014] (2) Add compound I, 2-carboxybenzaldehyde and copper bromide to a sealable pressure-resistant tube equipped with a magnet, and heat the pressure-resistant tube at 140° C. for 5 hours. Separate and purify to obtain compound II;
[0015] (3) Pyridine was added dropwise to the solvent 1 containing p-methylthiophenol and BTC in a dry reaction bottle equipped with a magnetic rod, and the mixture was stirred at 0°C for 1 h. The compound p-hydroxybenzaldehyde and triethylamine were dissolved in the solvent 2 and mixed with the crude product to react for 10 h. Solid III was obtained by separation and purification.
[0016] (4) Add compound III and solvent to a reaction bottle equipped with a magnetic bar, and lower the temperature of the reaction solution to 0°C. Slowly add sodium borohydride to the reaction solution. After the addition is complete, stir at room temperature for 1 hour. Separate and purify to obtain solid IV.
[0017] (5) Add compound IV and solvent to a reaction bottle containing a magnetic particle, and lower the temperature of the reaction solution to 0°C. Slowly drop phosphorus tribromide into the reaction solution. After the dropwise addition is completed, slowly raise the reaction solution to room temperature and stir for 2 hours. Separate and purify to obtain solid V.
[0018] (6) Add compound II, compound V and solvent to a reaction bottle containing a magnetic particle, and stir at 60° C. for 12 hours to obtain the fluorescent probe VI through separation and purification.
[0019] Wherein, the strong base in step (1) is n-butyl lithium, and the organic solvent is tetrahydrofuran; the solvent 1 in step (3) is dichloromethane, and the solvent 2 is N,N-dimethylformamide; the solvent in step (4) is methanol; the solvent in step (5) is dichloromethane; and the solvent in step (6) is acetonitrile.
[0020] The preparation process of the preparation method can refer to the following equation:
[0021]
[0022] The present invention also provides the application of the fluorescent probe, which can be used for the detection of adrenaline and noradrenaline in the aqueous phase. Compared with the prior art, the present invention has the advantages that the silicon rhodamine fluorescent probe obtained by the present invention can achieve efficient detection of adrenaline and noradrenaline, can reach more than 10 times the background fluorescence in 60 minutes, and the emission wavelength reaches 668nm, has good pH universality, and has broad application prospects in the biomedical field. In addition, the synthesis method is simple and feasible, and the yield is high, so it is an ideal adrenaline and noradrenaline detection tool. BRIEF DESCRIPTION OF THE DRAWINGS
[0023] Figure 1 is the hydrogen nuclear magnetic resonance spectrum of the reaction product I of Example 1;
[0024] Figure 2 is the hydrogen nuclear magnetic resonance spectrum of the reaction product II of Example 2;
[0025] Figure 3 is the hydrogen nuclear magnetic resonance spectrum of the reaction product III of Example 3;
[0026] Figure 4 is the hydrogen nuclear magnetic resonance spectrum of the reaction product IV of Example 4;
[0027] Figure 5 is the hydrogen nuclear magnetic resonance spectrum of the reaction product V of Example 5;
[0028] Figure 6 is the hydrogen nuclear magnetic resonance spectrum of the reaction product VI of Example 6;
[0029] Figure 7 is a graph showing the change in fluorescence intensity of probe VI in Example 7 in response to NE over time;
[0030] Figure 8 is a graph showing the change in fluorescence intensity of probe VI in response to EP over time in Example 7;
[0031] Fig. 9 is the linear fit of the probe VI to NE concentration and fluorescence intensity in Example 7;
[0032] Fig.10 is the linear fit of the probe VI to the EP concentration and the fluorescence intensity in Example 7;
[0033] Fig.11 is a fluorescence intensity graph of the selectivity experiment of probe VI in Example 7;
[0034] Fig.12 This is a test of the pH effect of probe VI in Example 7 on detecting NE. DETAILED DESCRIPTION
[0035] In order to make the purpose, technical solutions and advantages of the present invention more clearly understood, the present invention is further described in detail below in conjunction with the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention and are not intended to limit the present invention. It is impossible to list all implementation methods here. All technical solutions obtained by equivalent replacement or equivalent transformation methods fall within the protection scope of the present invention.
[0036] Example 1
[0037] Under nitrogen protection, 3-bromo-N, N-dimethylaniline (2.0 g, 10 mmol) and anhydrous tetrahydrofuran (26 mL) were added to a 250 mL dry flask equipped with a magnetic. The solution was cooled to -78 ° C, n-butyl lithium (2.5 M in n-hexane, 4.4 mL, 10.8 mmol) was added dropwise to the reaction flask, and stirring was continued at -78 ° C for 2 hours. Dichlorodimethylsilane (0.6 mL, 6.0 mmol) was added dropwise, and the reaction mixture was slowly warmed to room temperature and stirred for 12 hours. After the reaction was completed, water (40 mL) was added to quench, the solvent was removed under reduced pressure, and the organic phase was extracted with ethyl acetate (50 mL × 3), and the combined organic phase was washed with saturated brine and dried with anhydrous sodium sulfate. After the residual solvent was removed under reduced pressure, silica gel column chromatography (petroleum ether: ethyl acetate = 30: 1) was used to separate and purify to obtain 1.2 g of compound I (yellow oily liquid) with a yield of 80%.
[0038] Compound I 1H NMR (400MHz, Chloroform-d) δ: 7.35 (dd, J=8.0, 7.2Hz, 2H), 7.05 (d, J=2.7Hz, 2H ), 7.03 (d, J=7.1Hz, 2H), 6.87 (dd, J=8.2, 2.7Hz, 2H), 3.02 (s, 12H), 0.65 (s, 6H).
[0039] Example 2
[0040] Compound I (1.9 g, 6.4 mmol), o-carboxybenzaldehyde (4.8 g, 31.8 mmol) and copper bromide (0.14 g, 0.64 mmol) were added to a 25 mL pressure tube equipped with a magnetic rod. The pressure tube was heated at 140 ° C for 5 hours. After the reaction was completed, it was cooled to room temperature, and the reaction mixture was dissolved in 5 mL of dichloromethane and subjected to silica gel column chromatography (petroleum ether: ethyl acetate: triethylamine = 15: 1: 1) to obtain 1.0 g of compound II (white solid) with a yield of 37%.
[0041] Compound II 1 H NMR (400MHz, Chloroform-d) δ: 7.97 (d, J=7.5Hz, 1H), 7.65 (td, J=7.5, 1.2Hz, 1H). 7.55 (td, J=7.5, 1.0Hz, 1H), 7.34-7.30 (m, 1H), 6.98 (d, J=2.9Hz, 2H), 6.79 (d, J=8.9Hz, 2H), 6.55 (dd, J=8.9, 2.9Hz, 2H), 2.97 (s, 12H), 0.65 (s, 3H), 0.62 (s, 3H).
[0042] Example 3
[0043] In a dry reaction bottle equipped with a magnetic separator, pyridine (14.0 mmol, dissolved in 5 mL CH 2 Cl 2 ) was added dropwise to a solution of p-methylthiophenol (1.8 g, 14 mmol) and BTC (2.1 g, 7.0 mmol) in CH 2 Cl 2 The solution was stirred at 0°C for 1h, then poured into 100mL of ice water. The organic layer was separated, washed with brine, dried over anhydrous sodium sulfate, the solvent was removed under reduced pressure, and used directly in the next step without purification. The compound p-hydroxybenzaldehyde (0.17g, 1.4mmol) and triethylamine (0.28g, 2.8mmol) were dissolved in 10mL DMF and mixed with the previous crude product (0.46g in 5mL CH 2 Cl 2After the mixture was reacted for 10 h, the solvent was removed under reduced pressure and the residue was purified by column chromatography using (petroleum ether:ethyl acetate=5:1) as eluent to obtain 0.37 g of compound III (white solid) with a yield of 98%.
[0044] Compound III 1 H NMR (400 MHz, Methanol-d 4 )δ: 9.97 (s, 1H), 7.97 (d, J = 8.8Hz, 2H), 7.49 (d, J = 8.2Hz, 2H), 7.40 (d, J = 8.6Hz, 2H), 7.29 (d, J = 7.4Hz, 2H), 2.38 (s, 3H).
[0045] Example 4
[0046] Compound III (0.57 g, 2.1 mmol) was added to a 100 mL reaction bottle equipped with a magnetic rod, methanol (10 mL) was added, and the reaction solution was cooled to 0 ° C. Sodium borohydride (0.16 g, 4.2 mmol) was slowly added to the reaction solution. Stir for 1 hour after the addition was completed. After the reaction was completed, an ice-saturated aqueous sodium chloride solution was slowly added dropwise to the reaction solution (20 mL). The organic phase was extracted with ethyl acetate (20 mL × 3), the combined organic phases were dried over anhydrous sodium sulfate, and the residual solvent was removed under reduced pressure. Silica gel column chromatography (petroleum ether: ethyl acetate = 1: 1) was used to separate and purify to obtain 0.55 g of compound IV (white solid) with a yield of 96%.
[0047] Compound IV 1 H NMR (400MHz, Chloroform-d) δ: 7.47 (d, J=8.2Hz, 2H), 7.37 (d, J=10.2Hz, 2H), 7.23 (d, J=7.9Hz, 2H), 7.17 (d, J=8.6Hz, 2H), 4.68 (s, 2H), 2.38 (s, 3H).
[0048] Example 5
[0049] Compound IV (0.24 g, 0.86 mmol) was added to a 100 mL reaction bottle equipped with a magnetic rod, and dichloromethane (10 mL) was added to reduce the reaction solution to 0 ° C. Phosphorus tribromide (0.08 mL, 0.86 mmol) was slowly added dropwise to the reaction solution. After the addition was completed, the reaction solution was slowly heated to room temperature and stirred for 2 hours. After the reaction was completed, the reaction was quenched with an ice-saturated aqueous sodium chloride solution (20 mL). The organic phase was extracted with dichloromethane (20 mL × 3), the combined organic phases were dried over anhydrous sodium sulfate, and the residual solvent was removed under reduced pressure. Silica gel column chromatography (petroleum ether: ethyl acetate = 10: 1) was used to separate and purify to obtain 0.26 g of compound V (white crystalline solid) with a yield of 88%.
[0050] Compound V 1 H NMR (400MHz, Chloroform-d) δ: 7.49 (d, J=8.2Hz, 2H), 7.40 (d, J=8.7Hz, 2H), 7.25 (d, J=7.9Hz, 2H), 7.17 (d, J=8.6Hz, 2H), 4.47 (s, 2H), 2.39 (s, 3H).
[0051] Example 6
[0052] Compound V (0.030 g, 0.09 mmol), acetonitrile (2 mL) and compound II (0.058 g, 0.14 mmol) were added to a 10 mL reaction bottle equipped with a magnetic rod, and the mixture was reacted at 60°C for 12 hours. After the reaction, the solvent was removed under reduced pressure, and the remaining reaction mixture was separated and purified by silica gel column chromatography (dichloromethane: methanol = 10: 1) to obtain 0.034 g of compound VI (white oily solid) with a yield of 56%, which was used as a fluorescent probe.
[0053] Compound VI 1 H NMR (400MHz, Chloroform-d) δ: 8.07 (s, 1H), 7.94 (d, J=7.6Hz, 1H), 7.63 (d, J=7.4Hz , 1H), 7.55 (d, J=7.4Hz, 1H), 7.41 (d, J=8.0Hz, 2H), 7.25 (d, J=7.6Hz, 1H), 7.18 (t, J =7.9Hz, 4H), 7.06 (d, J = 7.5Hz, 2H), 6.91 (t, J = 8.9Hz, 4H), 6.60 (dd, J-9.0, 2.64Hz, 1H), 5.53(s, 2H), 3.86(s, 6H), 2.98(s, 6H), 2.35(s, 3H), 0.70(s, 3H), 0.62(s, 3H).
[0054] Example 7
[0055] (1) Spectral properties of the response of 10 μM probe VI to NE at different times
[0056] The PB solution of probe VI (10 mM KH 2 PO 4 , 5 mM Na 2 S 2 O 3 , 12 mM NaCl, pH = 5.0), and its fluorescence emission spectrum was measured using a fluorescence spectrophotometer with 643 nm as the excitation light.
[0057] The emission spectrum is Figure 7 As shown, the probe responded quickly, with the fluorescence intensity increasing by about 10 times within 60 min.
[0058] (2) Spectral properties of 10 μM probe VI response to EP at different times
[0059] The PB solution of probe VI (10 mM KH 2 PO 4 , 5 mM Na 2 S 2 O 3 , 12 mM NaCl, pH = 5.0), and its fluorescence emission spectrum was measured using a fluorescence spectrophotometer with 643 nm as the excitation light.
[0060] The emission spectrum is Figure 8 The probe responded quickly, with the fluorescence intensity increasing by about 11 times within 60 min.
[0061] (3) Spectral properties of the response of 10 μM probe VI to different concentrations of NE
[0062] The PB solution of probe VI (10 mM KH 2 PO 4 , 5 mM Na 2 S 2 O 3 , 12 mM NaCl, pH = 5.0), and its fluorescence emission spectrum was measured using a fluorescence spectrophotometer with 643 nm as the excitation light.
[0063] The emission spectrum is linearly fitted as Fig. 9As shown, the change in probe fluorescence intensity showed a positive correlation with NE concentration.
[0064] (4) Spectral properties of the response of 10 μM probe VI to different concentrations of EP
[0065] The PB solution (10 mM KH2O) of probe VI was treated with 0.25 mM, 0.50 mM, 0.75 mM, 1.00 mM, 1.25 mM, 1.50 mM, 1.75 mM, 2.00 mM, 2.25 mM, 2.50 mM, 2.75 mM, 3.00 mM, 3.25 mM, 3.50 mM, 3.75 mM, 4.00 mM, 4.25 mM, 4.50 mM, 4.75 mM, and 5.00 mM EP, respectively. 2 PO 4 , 5 mM Na 2 S 2 O 3 , 12 mM NaCl, pH = 5.0), and its fluorescence emission spectrum was measured using a fluorescence spectrophotometer with 643 nm as the excitation light.
[0066] The emission spectrum is linearly fitted as Fig.10 As shown, the change in probe fluorescence intensity showed a positive correlation with EP concentration.
[0067] (5) Selectivity test of probe VI
[0068] 10 μM probe VI in PB solution (10 mM KH 2 PO 4 , 5 mM Na 2 S 2 O 3 , 12 mM NaCl, pH = 5.0), and its fluorescence emission spectrum was measured using a fluorescence spectrophotometer with 643 nm as the excitation light.
[0069] Fig.11 It was shown that probe VI specifically responded to NE and EP, but did not respond to other detection substances.
[0070] (6) Test on the effect of pH on NE detection.
[0071] Fig.12 It was shown that at different pH values, 10 μM probe VI had almost no effect on the fluorescence response to 2 mM NE.
[0072] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions and improvements made within the spirit and principles of the present invention should be included in the protection scope of the present invention.
Claims
1. A fluorescent probe for detecting adrenaline and norepinephrine, characterized in that: The probe consists of two parts, and the probe has a structure as shown in Formula VI:
2. A method for preparing a fluorescent probe for detecting epinephrine and norepinephrine as claimed in claim VI, characterized in that The following steps are involved: The structural compound II as shown in formula II is dissolved in acetonitrile, and compound V is added, and stirred at room temperature for 12 hours. After the reaction is completed, the solvent is evaporated under reduced pressure, and the fluorescent probe for detecting epinephrine and norepinephrine as shown in formula VI is obtained after separation and purification by silica gel column chromatography; 3. The preparation method according to claim 2, characterized in that The amount of the structural compound II used is 1.5 times the molar amount of the compound V.
4. The preparation method according to claim 2, characterized in that During the silica gel column chromatography separation and purification, methanol: dichloromethane with a volume ratio of 1:10 is used as the eluent.
5. A use of the fluorescent probe as claimed in claim 1, characterized in that: The probe can be used for the detection of adrenaline and norepinephrine.
Citation Information
Patent Citations
Synthesis and application of silicon rhodamine-based hydrogen peroxide (H2O2) detection fluorescent probe
CN117986288A
Two-photon fluorescent probe for rapidly detecting noradrenaline, preparation method of two-photon fluorescent probe and application of two-photon fluorescent probe in cell imaging and biosensing
CN118164901A
Synthesis and application of biological thiol detection fluorescent probe based on 2, 4-dinitrophenoxy group
CN118324795A
Synthesis and application of superoxide anion free radical detection fluorescent probe based on silicon rhodamine
CN118324796A
Synthesis and application of biological thiol detection fluorescent probe based on silicon rhodamine
CN118324797A
